Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 35,000 | 12,595 | 267,630 | 344,775 | 0 |
| Gross Profit | 35,000 | 12,595 | 267,630 | 344,775 | N/A |
| Operating Expenses | 194,528 | 163,696 | 141,306 | 99,874 | 45,240 |
| Operating Income | -159,528 | -151,101 | 126,324 | 244,901 | -45,240 |
| Other Income | 39,186 | 42,071 | 22,412 | 11,563 | 7,150 |
| Pre-tax Income | -120,342 | -109,030 | 148,736 | 256,464 | -38,090 |
| Income Tax | 14,072 | 3,612 | 52,084 | 41,943 | -57 |
| Net Income Continuous | -134,414 | -112,642 | 96,652 | 214,521 | -38,033 |
| Net Income | $-134,414 | $-112,642 | $96,652 | $214,521 | $-38,033 |
| EPS Basic Total Ops | -3.32 | -3.15 | 2.72 | 6.10 | -2.88 |
| EPS Basic Continuous Ops | -3.32 | -3.15 | 2.72 | 6.10 | -2.52 |
| EPS Diluted Total Ops | -3.32 | -3.15 | 2.56 | 5.68 | -2.88 |
| EPS Diluted Continuous Ops | -3.32 | -3.15 | 2.56 | 5.68 | -2.52 |
| EPS Diluted Before Non-Recurring Items | -3.32 | -3.15 | 2.56 | 5.68 | -2.88 |
| EBITDA(a) | $-169,808 | $-160,437 | $125,399 | $245,504 | $-44,705 |